We are a biotech company that originated from the University of Tokyo, supporting the preclinical phase of drug discovery using biotechnology and digital technologies, including 3D imaging technology CUBIC and next-generation epitope mapping service DECODE. With CUBIC technology, we can quantitatively analyze the pharmacokinetics and efficacy verification in three dimensions. Furthermore, using DECODE, we can identify the specificity of epitopes recognized by antibodies at the highest global standard. By utilizing our services, we enable the reduction of the drug discovery timeline.